MCA Stability Tool

This compatibility recommendation is derived from Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) and Caramet 25mg/100mg CR tablets (Teva UK Ltd).

Incompatible

Carbaglu 200mg dispersible tablets (Recordati Rare Diseases UK Ltd)

Explore other Carglumic acid formulations Explore other Carglumic acid 200mg dispersible tablets sugar free suppliers

Stability Notes

Dispersible tablet so unsuitable.

Provenance

This compatibility recommendation is derived from Carbaglu 200mg dispersible tablets (Recordati Rare Diseases UK Ltd).

Use with caution

Carbamazepine 100mg tablets (A A H Pharmaceuticals Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 100mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 100mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 100mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 100mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 100mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 100mg tablets (Crescent Pharma Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 100mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 100mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 100mg tablets (Medihealth (Northern) Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 100mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 100mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 100mg tablets (Medreich Plc)

Explore other Carbamazepine formulations Explore other Carbamazepine 100mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 100mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 100mg tablets (Noumed Life Sciences Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 100mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 100mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 200mg modified-release tablets (Drugsrus Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 200mg modified-release tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container.

Provenance

This compatibility recommendation is derived from Tegretol Prolonged Release 200mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 200mg tablets (A A H Pharmaceuticals Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 200mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 200mg tablets (Novartis Pharmaceuticals UK Ltd).

Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Use with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.